Tokyo Tape
Sign in
← Meiji Holdings

Half-year report · Q2

2269.TEDINET S100UP1S
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥569.0bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥1.11T2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥546.0bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥44.4bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥44.4bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥43.3bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥76.0bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥43.4bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥44.3bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥48.1bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥26.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥50.7bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥27.9bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥29.5bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥30.4bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥1.18Tat 2024-09-30Cons.Assets
Total assets¥1.21Tat 2024-03-31Cons.Assets
Total assets¥1.21Tat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥401.2bnat 2024-09-30Cons.Liabilities
Total liabilities¥417.5bnat 2024-03-31Cons.Liabilities
Net assets / equity¥774.6bnat 2024-09-30Cons.Net assets
Net assets / equity¥787.8bnat 2024-03-31Cons.Net assets
Net assets / equity¥786.7bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥78.8bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥106.9bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥73.4bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥102.8bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥78.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥60.9bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥3.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥108.0bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥25.9bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥12.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥24.6bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥15.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥17.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥43.8bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥97.662024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥181.642023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥100.132023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio62.2%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio61.9%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio61.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥318m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥318m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥1.8bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue2024-04-01 → 2024-09-30¥455.4bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue external2024-04-01 → 2024-09-30¥455.1bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥307m
jpcrp040300-q2r_E21902-000Foodreportable segmentsegment profit2024-04-01 → 2024-09-30¥27.6bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue2024-04-01 → 2024-09-30¥113.9bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue external2024-04-01 → 2024-09-30¥113.9bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥10m
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentsegment profit2024-04-01 → 2024-09-30¥18.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥569.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥569.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥318m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥46.2bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥303m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥303m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥1.1bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue2023-04-01 → 2023-09-30¥445.5bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue external2023-04-01 → 2023-09-30¥445.2bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥293m
jpcrp040300-q2r_E21902-000Foodreportable segmentsegment profit2023-04-01 → 2023-09-30¥29.7bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue2023-04-01 → 2023-09-30¥100.9bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue external2023-04-01 → 2023-09-30¥100.8bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥9m
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentsegment profit2023-04-01 → 2023-09-30¥15.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥546.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥546.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥303m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥45.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 542
ItemContextValueUnit
Noncurrent assetsCurrentQuarterInstant634842000000JPY
AssetsPrior1YearInstant1205288000000JPY
AssetsCurrentQuarterInstant1175765000000JPY
Notes and accounts payable tradePrior1YearInstant127348000000JPY
Notes and accounts payable tradeCurrentQuarterInstant105379000000JPY
Short term loans payablePrior1YearInstant22330000000JPY
Short term loans payableCurrentQuarterInstant43466000000JPY
Commercial papers liabilitiesPrior1YearInstant－JPY
Commercial papers liabilitiesCurrentQuarterInstant10000000000JPY
Accrued expensesPrior1YearInstant37377000000JPY
Accrued expensesCurrentQuarterInstant34178000000JPY
Income taxes payablePrior1YearInstant17122000000JPY
Income taxes payableCurrentQuarterInstant15220000000JPY
Contract liabilitiesPrior1YearInstant353000000JPY
Contract liabilitiesCurrentQuarterInstant495000000JPY
Return liabilityPrior1YearInstant17876000000JPY
Return liabilityCurrentQuarterInstant18883000000JPY
Provision for bonusesPrior1YearInstant11461000000JPY
Provision for bonusesCurrentQuarterInstant10979000000JPY
Other clPrior1YearInstant88475000000JPY
Other clCurrentQuarterInstant70878000000JPY
Current liabilitiesPrior1YearInstant322345000000JPY
Current liabilitiesCurrentQuarterInstant309482000000JPY
Bonds payablePrior1YearInstant10000000000JPY
Bonds payableCurrentQuarterInstant10000000000JPY
Long term loans payablePrior1YearInstant17596000000JPY
Long term loans payableCurrentQuarterInstant14236000000JPY
Deferred tax liabilitiesPrior1YearInstant4754000000JPY
Deferred tax liabilitiesCurrentQuarterInstant4230000000JPY
Net defined benefit liabilityPrior1YearInstant54384000000JPY
Net defined benefit liabilityCurrentQuarterInstant54494000000JPY
Provision for directors retirement benefitsPrior1YearInstant87000000JPY
Provision for directors retirement benefitsCurrentQuarterInstant75000000JPY
Other nclPrior1YearInstant8326000000JPY
Other nclCurrentQuarterInstant8692000000JPY
Noncurrent liabilitiesPrior1YearInstant95149000000JPY
Noncurrent liabilitiesCurrentQuarterInstant91729000000JPY
LiabilitiesPrior1YearInstant417494000000JPY
LiabilitiesCurrentQuarterInstant401211000000JPY
Capital stockPrior1YearInstant30000000000JPY
Capital stockCurrentQuarterInstant30000000000JPY
Capital surplusPrior1YearInstant72410000000JPY
Capital surplusCurrentQuarterInstant72501000000JPY
Retained earningsPrior1YearInstant626158000000JPY
Retained earningsCurrentQuarterInstant638869000000JPY
Treasury stockPrior1YearInstant-38236000000JPY
Treasury stockCurrentQuarterInstant-67745000000JPY
Shareholders equityPrior1YearInstant690332000000JPY
Shareholders equityCurrentQuarterInstant673626000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant21722000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass